Tribe, Drugmaker Heading To Supreme Court After Bids For Rehearing, Stay Denied

Mealey's (November 16, 2018, 9:09 AM EST) -- WASHINGTON, D.C. — A Native American tribe and a drug company are taking their fight to use the tribe’s sovereign immunity to shield it from inter partes review (IPR) of patents to the U.S. Supreme Court, though the Federal Circuit U.S. Court of Appeals on Nov. 13 said it will not stay its opinion affirming the ruling while a certiorari petition runs its course (Saint Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., Nos. 2018-1638, -1639, -1640, -1641, -1642, -1643, Fed. Cir.)....